Controlled, targeted, intracellular expression of ribozymes: progress and problems

Trends in Biotechnology
J J Rossi

Abstract

Significant progress has been made in the development of ribozymes for a wide variety of intracellular applications, including human gene therapy. Further advances are likely to come from innovative strategies to improve the delivery, expression, co-localization, targeting specificity and substrate turnover of ribozymes. In order to stimulate problem solving in these areas, this article discusses examples of recent successes in intracellular ribozyme applications, and identifies some of the obstacles that remain. In addition, some testable, but as yet untried, ideas for overcoming several of these obstacles are presented.

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M Gossen, H Bujard
Apr 15, 1992·Gene·R PerrimanW L Gerlach
Nov 27, 1990·Biochemistry·D E RuffnerO C Uhlenbeck
Oct 1, 1993·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D Ding, H D Lipshitz
Aug 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·L CagnonA Doglio
Oct 1, 1993·Science·Z TsuchihashiD Herschlag
Nov 5, 1993·Cell·M Rosbash, R H Singer

❮ Previous
Next ❯

Citations

Jan 8, 2005·Chembiochem : a European Journal of Chemical Biology·Michael Famulok, Günter Mayer
Jan 1, 1997·Journal of Cancer Research and Clinical Oncology·M Y ChangH S Liu
Aug 1, 1997·Molecular Biotechnology·A Menke, G Hobom
Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Y BouffardK J Scanlon
Jul 13, 2000·Journal of Biochemical and Biophysical Methods·T NyholmL Ahrlund-Richter
Nov 5, 2002·Trends in Biotechnology·Michael Famulok, Sandeep Verma
Nov 10, 2000·Advanced Drug Delivery Reviews·L A Phylactou
Aug 13, 1998·RNA·T K Stage-Zimmermann, O C Uhlenbeck
Jun 13, 1998·Nature Biotechnology·M Sioud, D R Sørensen
Apr 16, 1998·Nature Genetics·L A PhylactouM J Wood
Jun 16, 2005·Nature Reviews. Molecular Cell Biology·Hideo AkashiKazunari Taira
Feb 15, 2001·The Biochemical Journal·R Goila, A C Banerjea
Apr 1, 1997·European Journal of Biochemistry·K R BirikhF Eckstein
Dec 19, 2002·The Journal of Clinical Investigation·Christopher S RogersAlfred L George
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A SamarskyM J Fournier
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·S ShahiA C Banerjea
Jul 19, 2001·Cancer Investigation·L Wright, P Kearney
Aug 29, 2013·Reviews in Medical Virology·Cristina Romero-López, Alfredo Berzal-Herranz
Oct 9, 2001·Chemistry & Biology·M FamulokG Mayer
Mar 4, 2006·Bioorganic & Medicinal Chemistry Letters·Douglas D Young, Alexander Deiters
Nov 5, 1997·Nature Biotechnology·A Persidis
Mar 14, 2009·Chemical Communications : Chem Comm·Douglas D YoungAlexander Deiters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.